Center of Biomedical Research, Sanjay Gandhi Post-Graduate Institute of Medical Sciences Campus, Raebareli Road, Lucknow, 226014, India.
Sci Rep. 2020 Sep 25;10(1):15825. doi: 10.1038/s41598-020-71761-w.
Chemical fixation of CO as a C1 feedstock for producing value-added products is an important post-combustion technology reducing the CO emission. As it is an irreversible process, not considered for the CO capture and release. Overall, these chemical transformations also do not help to mitigate global warming, as the energy consumed in different forms is much higher than the amount of CO fixed by chemical reactions. Here we describe the development of re-generable chemical fixation of CO by spiroaziridine oxindole, where CO is captured (chemical fixation) under catalyst-free condition at room temperature both in aqueous and non-aqueous medium even directly from the slow stream of flue gas producing regioselectively spirooxazolidinyl oxindoles, a potential drug. The CO-adduct is reversed back to the spiroaziridine releasing CO under mild conditions. Further both the fixation-defixation of CO can be repeated under near ambient conditions for several cycles in a single loop using a recyclable reagent.
将 CO 化学固定作为生产增值产品的 C1 原料是一种减少 CO 排放的重要后燃烧技术。由于这是一个不可逆的过程,因此不考虑 CO 的捕获和释放。总的来说,这些化学转化也无助于缓解全球变暖,因为不同形式消耗的能量远远高于化学反应固定的 CO 量。在这里,我们描述了通过螺恶嗪吲哚开发可再生物质化学固定 CO 的方法,其中 CO 在无催化剂条件下在室温下在水相和非水相介质中被捕获(化学固定),甚至直接从烟道气的缓慢流中,以区域选择性方式生成螺恶唑啉基吲哚,这是一种潜在的药物。在温和条件下,CO-加合物被反转回螺恶嗪,释放 CO。进一步,在接近环境条件下,使用可回收试剂,在单个循环中可以重复进行 CO 的固定-脱固定多次循环。